Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
about
Interferon-γ: The Jekyll and Hyde of MalariaCerebral malaria: gamma-interferon reduxThe Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruziPerivascular Arrest of CD8+ T Cells Is a Signature of Experimental Cerebral MalariaExperimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierReal-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesisRegulation of immunopathogenesis during Plasmodium and Toxoplasma infections: more parallels than distinctions?Splenic differentiation and emergence of CCR5+CXCL9+CXCL10+ monocyte-derived dendritic cells in the brain during cerebral malaria.Plasmodium falciparum histidine-rich protein II causes vascular leakage and exacerbates experimental cerebral malaria in mice.Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease.Interferons and interferon regulatory factors in malariaThe subcellular location of ovalbumin in Plasmodium berghei blood stages influences the magnitude of T-cell responses.Damage to the blood-brain barrier during experimental cerebral malaria results from synergistic effects of CD8+ T cells with different specificitiesMalaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen.Phosphatidylinositol 3-Kinase γ is required for the development of experimental cerebral malaria.IRGM3 contributes to immunopathology and is required for differentiation of antigen-specific effector CD8+ T cells in experimental cerebral malariaActivated Brain Endothelial Cells Cross-Present Malaria AntigenInhibiting the Mammalian target of rapamycin blocks the development of experimental cerebral malaria.Targeting glutamine metabolism rescues mice from late-stage cerebral malaria.CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature.A quantitative brain map of experimental cerebral malaria pathology.Mycobacterium tuberculosis Coinfection Has No Impact on Plasmodium berghei ANKA-Induced Experimental Cerebral Malaria in C57BL/6 Mice.A TCRβ Repertoire Signature Can Predict Experimental Cerebral Malaria.Defining rules of CD8(+) T cell expansion against pre-erythrocytic Plasmodium antigens in sporozoite-immunized mice.Discriminating Protective from Nonprotective Plasmodium-Specific CD8+ T Cell ResponsesMice lacking Programmed cell death-1 show a role for CD8(+) T cells in long-term immunity against blood-stage malariaPlasmodium falciparum Histidine-Rich Protein II Compromises Brain Endothelial Barriers and May Promote Cerebral Malaria Pathogenesis.The Deubiquitinating Enzyme Cylindromatosis Dampens CD8+ T Cell Responses and Is a Critical Factor for Experimental Cerebral Malaria and Blood-Brain Barrier DamageTargeting Angiotensin II Type-1 Receptor (AT1R) Inhibits the Harmful Phenotype of Plasmodium-Specific CD8+ T Cells during Blood-Stage Malaria.Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?Pathogenic CD8+ T cells in experimental cerebral malaria.The immunological balance between host and parasite in malaria.Evidence of cross-stage CD8+ T cell epitopes in malaria pre-erythrocytic and blood stage infections.Investigating proteasome inhibitors as potential adjunct therapies for experimental cerebral malaria.Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections.Mechanism of splenic cell death and host mortality in a Plasmodium yoelii malaria model.Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema during Experimental Cerebral Malaria.Plasmodium attenuation: connecting the dots between early immune responses and malaria disease severitySpatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection.
P2860
Q26782988-331A74A8-F579-4853-BF24-822E6BB4A5FDQ26824074-0A4411C3-2BB6-4B68-A112-36367E283D6AQ27314524-FDC04D3C-2B59-49BE-A50D-FC5007EF035CQ27316972-EDF08E01-2188-49C5-B8A8-E683CCC64C48Q27322655-2744D5BB-D463-4B63-AA58-D741BB857A8AQ27324676-111ED0A4-FA7E-4A9C-AEE1-1C40AA839DD1Q30409386-8AC229C4-8B9C-45E5-BB91-B4CCC495BBA7Q30827689-72C63DCC-21A3-44E6-B205-CE6FC33CF90BQ33643161-5DA56D56-FB85-4A04-AA5A-CD26F4139D60Q33721737-62503C44-DF61-4AF4-B0AB-C74ED1DA52AFQ33821137-AB84483A-E13B-428D-BDA0-73E9BEB8EC3CQ34012443-B53286F3-D123-4B27-9F8A-36CE43284FBBQ34595996-12EE0D21-4DE8-4199-8A17-41B541B51CDAQ34596034-555E55EB-D08B-469A-9B77-167DD5159B5EQ35072346-4857F1AC-7F0A-489D-A9BF-B992A47B0427Q35182051-77ACA531-1D89-43F8-A12C-FC4AA74821EEQ35187600-8275CB2A-D573-45F3-B87B-41EFAC3EECD4Q35654132-9044FD4E-140E-4C69-B912-0E3AB3EC6216Q35676305-C2CEA693-CE98-43FD-B740-8C9352E0A2DEQ36207221-85C8C6AB-BA09-4157-9DB8-B95FF3AD1A52Q36210506-5CDE9346-E8F0-4C00-B907-07E7DCE9D955Q36300874-407CC6BC-92CA-48F3-B72A-68A34CB024C0Q36513451-2C2B26A4-1962-4330-ACB8-9D9904DEDDA5Q36546844-C834FE16-A3AB-4411-BBCB-7A12D0E16964Q36836498-37E103F5-0139-4B99-AA78-2068E417D347Q36905568-C0B41F66-128B-47A7-85EC-E3FEB10171B0Q36928686-5763B11C-3420-4B8A-9C2C-ED0A67BCD4C2Q37123466-102ABA93-5D99-4762-B1C5-BD11A0A30570Q37617439-801CEB80-B477-43AD-BEF0-24B5C5DE5ED5Q37643882-1440EB8C-1DE6-48FB-9482-3D43AE32E504Q38182192-E7721746-A7E6-4E41-BBB8-217E70BE36EEQ38378859-818F7AEC-5F46-457C-8C18-1517E8D69172Q38666558-99DEC8C3-3523-44C8-AD1C-4C580C1B8C59Q38852479-5D0753B8-DB17-4951-9902-E09A3E035D49Q38964327-D74F8CD7-C5EF-418D-95C1-EF15A3B8F3CFQ40047603-C56343B0-CCE8-48C6-9913-8156A825020EQ40065575-0C4905DB-1027-4D9A-988F-D723068671CCQ40306137-0204C516-1F14-4C8B-A3E6-284FBFABC5A0Q41593015-BB389C29-7469-4668-98A6-2522625B245BQ41699908-AA84AD03-CEEA-43D7-931E-C6833DAB6925
P2860
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@en
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@nl
type
label
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@en
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@nl
prefLabel
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@en
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@nl
P2093
P2860
P50
P356
P1476
Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
@en
P2093
Chek Meng Poh
Florent Ginhoux
Gijsbert M Grotenbreg
Nilabh Shastri
P2860
P304
P356
10.1002/EMMM.201202273
P577
2013-05-16T00:00:00Z